Scholar Rock Holding sell Fitzi
Start price
10.10.24
/
0%
€23.40
Target price
10.10.25
-
Performance (%)
45.30%
End price
11.10.25
€34.00
Summary
This prediction ended on 11.10.25 with a price of €34.00. The price for Scholar Rock Holding massively increased, which is bad news for the SELL prediction by Fitzi. This prediction was marked as speculative and is excluded from Fitzi's performance statistics.Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Scholar Rock Holding | -8.290% | -8.290% | 11.321% |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % |
Comments by Fitzi for this prediction
In the thread Scholar Rock Holding diskutieren
Sell Scholar Rock Holding
In the thread Trading Scholar Rock Holding
Die von Fitzi gewählte maximale Laufzeit wurde überschritten